国际肿瘤学杂志››2014,Vol. 41››Issue (11): 801-804.doi:10.3760/cma.j.issn.1673422X.2014.11.001
• 综述 •下一篇
朱超, 钱军
出版日期:
2014-12-03发布日期:
2015-01-20通讯作者:
钱军,Email: qianjun215036@sina.com基金资助:
国家自然科学基金(8117386)
Chao, Qian Jun
Online:
2014-12-03Published:
2015-01-20Contact:
Qian Jun, Email: qianjun215036@sina.com摘要:侧群细胞(SP)是指利用荧光染料Hoechst33342外排特性而筛选出来的细胞群体。SP具有肿瘤干细胞特性,在肿瘤的发生、发展中发挥极其重要的作用。目前国内外对于各类常见恶性肿瘤SP都进行了较为广泛的研究。对SP的研究可为肿瘤的诊断和治疗提供新的思路和方法。
朱超, 钱军. 常见恶性肿瘤侧群细胞的研究进展[J]. 国际肿瘤学杂志, 2014, 41(11): 801-804.
ZHU Chao, QIAN Jun. Side population cells of common tumor[J]. Journal of International Oncology, 2014, 41(11): 801-804.
[1] Xiang W, Shi JF, Li P, et al. Estimation of cancer cases and deaths attributable to infection in China[J]. Cancer Causes Control, 2011, 22(8):11531161. [2] Garvalov BK, Acker T. Cancer stem cells:a new framework for the design of tumor therapies [J]. J Mol Med, 2011, 89(2):95107. [3] Valent P, Bonnet D, De Maria R, et al. Cancer stem cells definitions and terminology:the devil is in thedetails[J]. Cancer, 2012, 11(12):767775. [4] Shackleton M. Normal stem cells and cancer stem cells:similar and different[J]. Semin Cancer Biol, 2010, 20(2):8592. [5] Deonarain MP, Kousparou CA, Epenetos AA. Antibodies targeting cancer stem cells:a new paradigm in immunotherapy[J].MAbs, 2009, 1(1):1225. [6] Hittelman WN, Liao Y, Wang L, et al. Are cancer stem cells radioresistant[J]. Future Oncol, 2010, 6(10):15631576. [7] Fong D, Yeh A, Naftalovich R, et al. Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line:towards targeting of cancer stem cells with phytochemicals[J]. Cancer Lett, 2010, 293(1):6572. [8] Lan L, Cui D, Nowka K, et al. Stem cells derived from goiters in adults form spheres in response to intense growth stimulation and require thyrotropin for differentiation into thyrocytes[J]. J Clin Endocrinol Metab, 2007, 92(9):36813688. [9] Todaro M, Iovino F, Eterno V, et al. Tumorigenic and metastatic activity of human thyroid cancer stem cells[J]. Cancer Res, 2010, 70(21):88748885. [10] Mitsutake N, Iwao A, Nagai K, et al. Characterization of side population in thyroid cancer cell lines cancer stem like cells are enriched partly but not exclusively [J]. Endocrinology, 2007, 148(4):17971803. [11] 张菀姣, 兰玲, 郑旭琴, 等. 甲状腺癌中类干细胞的侧群细胞的分离及鉴定[J].南京医科大学学报, 2012, 32(5):585591. [12] 黄哲宙, 陈万青, 吴春晓, 等. 中国女性乳腺癌的发病和死亡现况——全国32个肿瘤登记点 2003—2007年资料分析报告[J]. 肿瘤, 2012, 23(6):435439. [13] Xu W, Lin H, Zhang Y, et al. Compound Kushen Injection suppresses human breast cancer stemlike cells by down regulating the canonical Wnt/catenin pathway[J]. J Exp Clin Cancer Res, 2011, 30:103. [14] Nakanishi T, Chumsri S, Khakpour N, et al. Side population cells in luminal type breast cancer have tumourinitiating cell properties,and are regulated by HER2 expression and signaling[J]. Br J Cancer, 2010, 102( 5):815826. [15] 杨晓宁, 周艳, 齐晓伟, 等. 成骨细胞诱导乳腺癌侧群细胞获得骨模拟特性的研究[J]. 第三军医大学学报, 2013, 35(11):11021106. [16] 孙欣, 樊翀, 胡丽娟, 等. Let7维持乳腺癌干细胞的特性及机制的研究[J]. 细胞与分子免疫学杂志, 2012, 28(8):789792. [17] Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):6990. [18] Li H, Gao Q, Guo L, et al. The PTEN/PI3K/Akt pathway regulates stemlike cells in primary esophageal carcinoma cells[J]. Cancer Biol Ther, 2011, 11(11):950958. [19] Yu X, Jiang X, Li H, et al. miR203 Inhibits the proliferation and selfrenewal of esophageal cancer stemlike cells by suppressing stem renewal factor Bmi1[J]. Stem Cells Dev, 2014, 23(6):576585. [20] Siegel R, Ma J, Zou Z, et al. Cancer statistics,2014[J]. CA Cancer J Clin, 2014, 64(1):929. [21] Singh S, Trevino J, BoraSinghal N, et al. EGFR/Src/Akt signaling modulates Sox2 expression and selfrenewal of stemlike sidepopulation cells in nonsmall cell lung cancer[J]. Mol Cancer, 2012, 11:73. [22] Hua S, Xiaotao X, Renhua G, et al. Reduced miR31 and let7 maintain the balance between differentiation and quiescence in lung cancer stemlike side population cells[J].Biomed Pharmacother, 2012,66(2):8997. [23] Hayashi S, Fujita K, Matsumoto S, et al. Isolation and identification of cancer stem cells from a side population of a human hepatoblastoma cell line, HuH6 clone5[J]. Pediatr Surg Int, 2011, 27(1):916. [24] Zhai JM, Yin XY, Hou X, et al. Analysis of the genomewide DNA methylation profile of side population cells in hepatocellular carcinoma[J]. Dig Dis Sci, 2013, 58(7):19341947. [25] Meyer HJ, Wilke H. Gastric cancer:current status of multimodalitytreatment[J]. Zentralbl Chir, 2011, 136(4):317324. [26] Dikken JL, van de Velde CJ, Coit DG, et al. Treatment of resectable gastric cancer[J]. Therap Adv Gastroenterol, 2012, 5(1):4969. [27] Zhang HH, Cai AZ, Wei XM, et al. Characterization of cancer stemlike cells in the side population cells of human gastric cancer cell line MKN45[J]. J Zhejiang Univ Sci B, 2013, 14(3):216223. [28] Li R, Wu X, Wei H, et al. Characterization of side population cells isolated from the gastric cancer cell line SGC7901[J].Oncol Lett, 2013, 5(3):877883. [29] Hasegawa T, Yashiro M, Nishii T, et al. Cancerassociated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factorβ signaling[J]. Int J Cancer, 2014, 134(8):17851795. [30] López J, Poitevin A, MendozaMartínez V, et al. Cancerinitiating cells derived from eslablished cervical cell lines exhibit stemcell markers and increased radioresistance[J]. BMC Cancer, 2012, 12:48. [31] Shishido Y, Ueno S, Yamazaki R, et al. ABCG2 inhibitor YHO13351 sensitizes cancer stem/initiatinglike side population cells to irinotecan[J]. Anticancer Res, 2013, 33(4):13791386. [32] Qi W, Zhao C, Zhao L, et al. Sorting and identification of side population cells in the human cervical cancer cell line HeLa[J]. Cancer Cell Int, 2014, 14(1):3. |
[1] | 刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325. |
[2] | 杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337. |
[3] | 袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343. |
[4] | 陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349. |
[5] | 郭泽浩, 张俊旺.PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353. |
[6] | 张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358. |
[7] | 许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363. |
[8] | 王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369. |
[9] | 张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375. |
[10] | 高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381. |
[11] | 王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384. |
[12] | 刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273. |
[13] | 杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279. |
[14] | 王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285. |
[15] | 张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||